1. Home
  2. WVE vs HNI Comparison

WVE vs HNI Comparison

Compare WVE & HNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • HNI
  • Stock Information
  • Founded
  • WVE 2012
  • HNI 1944
  • Country
  • WVE Singapore
  • HNI United States
  • Employees
  • WVE N/A
  • HNI N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • HNI Office Equipment/Supplies/Services
  • Sector
  • WVE Health Care
  • HNI Consumer Discretionary
  • Exchange
  • WVE Nasdaq
  • HNI Nasdaq
  • Market Cap
  • WVE 2.4B
  • HNI 2.1B
  • IPO Year
  • WVE 2015
  • HNI N/A
  • Fundamental
  • Price
  • WVE $13.67
  • HNI $54.89
  • Analyst Decision
  • WVE Strong Buy
  • HNI Strong Buy
  • Analyst Count
  • WVE 10
  • HNI 1
  • Target Price
  • WVE $21.30
  • HNI $63.00
  • AVG Volume (30 Days)
  • WVE 1.4M
  • HNI 348.1K
  • Earning Date
  • WVE 11-12-2024
  • HNI 10-29-2024
  • Dividend Yield
  • WVE N/A
  • HNI 2.40%
  • EPS Growth
  • WVE N/A
  • HNI 159.58
  • EPS
  • WVE N/A
  • HNI 2.56
  • Revenue
  • WVE $53,610,000.00
  • HNI $2,563,700,000.00
  • Revenue This Year
  • WVE N/A
  • HNI $5.42
  • Revenue Next Year
  • WVE N/A
  • HNI $2.73
  • P/E Ratio
  • WVE N/A
  • HNI $21.40
  • Revenue Growth
  • WVE N/A
  • HNI 10.36
  • 52 Week Low
  • WVE $3.50
  • HNI $38.55
  • 52 Week High
  • WVE $16.74
  • HNI $57.59
  • Technical
  • Relative Strength Index (RSI)
  • WVE 50.96
  • HNI 57.53
  • Support Level
  • WVE $14.95
  • HNI $54.29
  • Resistance Level
  • WVE $16.71
  • HNI $57.59
  • Average True Range (ATR)
  • WVE 1.04
  • HNI 1.35
  • MACD
  • WVE -0.28
  • HNI 0.38
  • Stochastic Oscillator
  • WVE 14.72
  • HNI 71.73

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About HNI HNI Corporation

HNI Corp is a provider of office furniture and hearth products. The company generates the bulk of its revenue from its workplace furnishing, which consists of panel-based and freestanding furniture systems, seating, storage, tables, and architectural products. These products are sold through a national system of dealers, wholesalers, and office product distributors but also directly to end-user customers and federal, state, and local governments. Residential building products include a full array of gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, and accessories. The company has operations in the United States, Canada, Mainland China, Hong Kong, India, Mexico, and Taiwan.

Share on Social Networks: